Clinical Trial Update: Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ATI-450 versus placebo in adults with moderate to severe psoriatic arthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• ATI-450

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Psoriatic Arthritis | Phase 2 | Status: TERMINATED